Back to Resource Hub Case Study

Enabling Remote Clinician Ratings in a Global Alzheimer's Study

When the COVID-19 pandemic threatened to disrupt an ongoing global Alzheimer's clinical trial, the sponsor sought a partner with the solutions and expertise to adapt the trial's clinical outcome assessments for remote clinician ratings.

The company selected Signant SmartSignals Electronic Clinician Ratings solution to help:

  • Adapt and migrate paper-based ClinRO assessments to an electronic format
  • Ensure accurate and consistent remote ratings
  • Equip home nurses with telemedicine technology to facilitate at-home assessments

Learn how Signant applied Electronic Clinical Ratings along with unrivaled expertise in Alzheimer's trials to ensure trial contuinity and endpoint data reliability. 

Similar posts

Looking for more insights? Explore related resources.

BROCHURE

Electronic Clinician Ratings

SEE THE BROCHURE
WHITE PAPER

Guidance for Implementing a Remote Assessment Strategy as a Protocol Adaptation During the COVID-19 Pandemic

READ THE PAPER
CASE STUDY

Signant's Central Rating Services Improved Signal Detection in 5 Major Depressive Disorder Trials

READ THE STUDY

Get notified on new marketing insights

Here mention the benefits of subscribing